AbbVie (XSWX:ABBV) Inventories, Inventories Adjustments: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABBV AbbVie Inc XSWX:ABBV
76 GF Score
Price CHF212.30
GF Value CHF176.84
! 5 Warning Signs
View Full Analysis

What is AbbVie Inventories, Inventories Adjustments?

AbbVie XSWX:ABBV 76 Inventories, Inventories Adjustments is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:ABBV with a GF Score™ of 76/100 and a GF Value™ of CHF176.84. The stock has 5 warning signs investors should review.

AbbVie's Inventories, Inventories Adjustments for the quarter that ended in Jun. 2026 was CHF0 Mil.

AbbVie Inventories, Inventories Adjustments Historical Data

* Premium members only.

The historical data trend for AbbVie's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie Inventories, Inventories Adjustments Chart

AbbVie Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Inventories Adjustments
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AbbVie Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:ABBV
76GF Score
AbbVie Inc XSWX:ABBV
Inventories, Inventories Adjustments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbbVie Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.

What does a Inventories, Inventories Adjustments of CHF0 Mil mean?
AbbVie (XSWX:ABBV) has a Inventories, Inventories Adjustments of CHF0 Mil as of Jun. 2026. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on AbbVie and its competitors.
Is AbbVie's Inventories, Inventories Adjustments too high?
AbbVie's current Inventories, Inventories Adjustments is CHF0 Mil. Overall, AbbVie has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Inventories, Inventories Adjustments compare to MRK and JNJ?
AbbVie's Inventories, Inventories Adjustments of CHF0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Inventories Adjustments for a Drug Manufacturers company?
A good Inventories, Inventories Adjustments depends on the Drug Manufacturers industry context. However, Inventories, Inventories Adjustments should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Inventories Adjustments mean?
A high Inventories, Inventories Adjustments can signal that a stock is expensive relative to its fundamentals. Inventories, Inventories Adjustments is certain charges made in the current period in inventory resulting from breakage, spoilage, etc. View historical data on AbbVie and its competitors. AbbVie's current Inventories, Inventories Adjustments is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
AbbVie (XSWX:ABBV) has a current Inventories, Inventories Adjustments of CHF0 Mil. The stock's GF Value™ is CHF176.84, compared to a current price of CHF212.30 — trading 20.1% above its estimated fair value. The current Inventories, Inventories Adjustments is CHF0 Mil. AbbVie's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Inventories Adjustments calculated?
Inventories, Inventories Adjustments is calculated from a company's financial statements. For AbbVie (XSWX:ABBV), the current Inventories, Inventories Adjustments is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AbbVie (XSWX:ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of CHF212.30 is trading 20.1% above its estimated GF Value™ of CHF176.84.

Key valuation signals for XSWX:ABBV:

  • Inventories, Inventories Adjustments: CHF0 Mil
  • GF Value™: CHF176.84 vs. price of CHF212.30 (20.1% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XSWX:ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
76GF Score

Get the complete analysis for XSWX:ABBV

Inventories, Inventories Adjustments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF212.30
Price
CHF176.84
GF Value